Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1924 1
1925 1
1927 2
1929 1
1947 1
1949 1
1951 1
1983 1
1984 3
1985 1
1986 2
1987 2
1988 9
1989 3
1990 4
1992 5
1993 3
1994 5
1995 4
1996 4
1997 6
1998 10
1999 15
2000 11
2001 17
2002 10
2003 22
2004 12
2005 10
2006 4
2007 4
2008 8
2009 9
2010 8
2011 6
2012 14
2013 16
2014 32
2015 33
2016 52
2017 52
2018 46
2019 51
2020 48
2021 36
2022 44
2023 18
2024 3

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26724178

603 results

Results by year

Filters applied: . Clear all
Page 1
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K; Blood Pressure Lowering Treatment Trialists' Collaboration. Nazarzadeh M, et al. Lancet Diabetes Endocrinol. 2022 Sep;10(9):645-654. doi: 10.1016/S2213-8587(22)00172-3. Epub 2022 Jul 22. Lancet Diabetes Endocrinol. 2022. PMID: 35878651 Free PMC article.
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Blood Pressure Lowering Treatment Trialists' Collaboration. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2021 Sep 18;398(10305):1053-1064. doi: 10.1016/S0140-6736(21)01921-8. Epub 2021 Aug 27. Lancet. 2021. PMID: 34461040 Free PMC article.
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC, Azevedo L, Copland E, Canoy D, Nazarzadeh M, Ramakrishnan R, Berge E, Sundström J, Kotecha D, Woodward M, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K; Blood Pressure Lowering Treatment Trialists’ Collaboration. Pinho-Gomes AC, et al. PLoS Med. 2021 Jun 1;18(6):e1003599. doi: 10.1371/journal.pmed.1003599. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34061831 Free PMC article.
603 results